Q4 2020 Holdings
Filed 2021-02-16 | 52 holdings | $44.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $9.1M | 84,544 | 20.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $7.3M | 1,126,675 | 16.5% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $5.8M | 1,078,177 | 13.1% |
| Adapthealth Corp(AHCO) | COM CL A | 00653Q102 | $5.7M | 150,414 | 12.8% |
| Aziyo Biologics Inc(ELUT) | COM CL A | 05479K106 | $5.6M | 408,213 | 12.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $5.5M | 194,777 | 12.4% |
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $2.8M | 184,901 | 6.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $2.3M | 38,313 | 5.2% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $39.1K | 2,240,421 | 0.1% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $17.3K | 69,264 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $15.1K | 244,066 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $9.6K | 655,741 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $8.9K | 56,231 | 0.0% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $8.0K | 193,008 | 0.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $7.7K | 78,339 | 0.0% |
| SI Bone Inc(SIBN) | COM | 825704109 | $7.6K | 254,907 | 0.0% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $7.6K | 179,138 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $7.3K | 22,634 | 0.0% |
| Syneos Health Inc(8IN) | CL A | 87166B102 | $6.9K | 101,953 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $6.4K | 681,243 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $6.1K | 66,585 | 0.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $6.0K | 73,104 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $6.0K | 290,465 | 0.0% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $5.5K | 204,384 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $5.4K | 207,293 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $5.2K | 25,085 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.8K | 28,378 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.1K | 124,323 | 0.0% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $4.0K | 19,834 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $3.7K | 172,047 | 0.0% |
| Mustang BIO Inc | COM | 62818Q104 | $3.4K | 892,027 | 0.0% |
| Goodrx Hldgs Inc(GDRX) | COM CL A | 38246G108 | $3.1K | 77,379 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $3.1K | 7,504 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $3.0K | 990,563 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $2.8K | 56,891 | 0.0% |
| PRA Health Sciences Inc(PRAH) | COM | 69354M108 | $2.7K | 21,590 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.5K | 54,221 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $2.4K | 133,648 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $2.1K | 138,613 | 0.0% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $2.1K | 12,691 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $2.1K | 477,895 | 0.0% |
| Eucrates Biomedical Acqu COR | UNIT 10/23/2027 | G3141W114 | $2.1K | 195,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $1.8K | 151,820 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $1.6K | 42,292 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $1.2K | 14,919 | 0.0% |
| Quotient LTD | SHS | G73268107 | $1.2K | 226,593 | 0.0% |
| Pennant Group Inc(PNTG) | COM | 70805E109 | $1.1K | 18,227 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $955 | 63,455 | 0.0% |
| Senseonics Hldgs Inc | NOTE 5.250% 2/0 | 81727UAA3 | $638 | 1,500,000 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $382 | 206,561 | 0.0% |